165 Views | 42 Downloads
Shi-Yong Sun, Ph.D., Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, 1365-C Clifton Road, C3088, Atlanta, GA 30322. Phone: (404) 778-2170; Fax: (404) 778-5520; Email: ssun@emory.edu
ZC had initial conception, designed and conducted most experiments, collected and analyzed data, and drafted manuscript; KAV and HC contributed to some experiments and manuscript writing. JZ and SSR contributed to project discussion, funding acquisition and manuscript editing. SYS had initial conception, supervised and coordinated the study, participated in data analyses, contributed to funding acquisition and completed the final version of the manuscript.
Zhen Chen: Conceptualization, Investigation, Formal analysis, Data curation and Writing – Original Draft and Writing - Review & Editing. Karin A. Vallega: Investigation, Writing – Original Draft and Writing - Review & Editing. Haiying Chen: Investigation, Writing – Original Draft. Jia Zhou: Supervision, Writing – Original Draft. Suresh S. Ramalingam: Supervision, Writing – Original Draft and Funding acquisition. Shi-Yong Sun: Conceptualization, Supervision, Project administration, Writing – Original Draft, Writing - Review & Editing and Funding acquisition.
SSR is on consulting/advisory boards for AstraZeneca, BMS, Merck, Roche, Tesaro and Amgen. Other authors declare that they have no competing interests.
This study was in part supported by the NIH/NCI R01 CA223220 (to SYS), R01 CA245386 (to SYS) and UG1 CA233259 (to SSR), Emory Winship Cancer Institute lung cancer research pilot funds (to SYS), and the John D. Stobo, M.D. Distinguished Chair Endowment Fund at UTMB (to JZ). SSR and SYS are Georgia Research Alliance Distinguished Cancer Scientists.